导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 25.47% | 149/1050 |
| 近一周 | -2.30% | 530/1104 |
| 近一月 | -6.58% | 773/1102 |
| 近一季 | -14.20% | 819/1092 |
| 近半年 | 23.36% | 110/1070 |
| 近一年 | 36.99% | 120/1018 |
| 近两年 | 204.18% | 49/926 |
| 近三年 | 161.67% | 49/834 |
| 成立以来 | 46.91% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.62% 603/1070 |
64.88% 160/1101 |
- - |
- - |
| 2025 | 73.69% 53/1065 |
5.04% 412/1014 |
1.26% 577/1038 |
58.56% 42/1050 |
2.99% 243/1065 |
| 2024 | 20.56% 85/1011 |
-2.39% 440/960 |
0.88% 248/983 |
8.32% 761/991 |
13.04% 43/1011 |
| 2023 | -18.14% 625/952 |
11.12% 90/880 |
0.59% 156/895 |
-21.81% 876/915 |
-6.34% 624/952 |
| 2022 | -34.15% 699/867 |
-19.54% 496/773 |
12.68% 169/806 |
-20.73% 767/845 |
-8.38% 748/867 |
| 2021 | -2.83% 394/740 |
-5.92% 381/580 |
18.24% 183/659 |
-8.38% 460/704 |
-4.66% 585/740 |
| 2020 | 61.99% 185/554 |
5.41% 70/419 |
31.16% 110/466 |
1.16% 409/517 |
15.83% 185/554 |
| 2019 | 63.58% 65/410 |
37.83% 91/1146 |
-5.99% 778/1228 |
12.73% 69/390 |
11.98% 110/410 |
| 2018 | -33.73% 259/349 |
- - |
-14.14% 729/990 |
-16.32% 956/1000 |
-12.65% 678/1080 |
| 2017 | 14.50% 113/285 |
- - |
- - |
- - |
- - |
| 2016 | -26.90% 142/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 摩根智慧互联股票A VS. 东吴新产业精选股票A(580008) |